Table 1. Beta-cell proliferation and number of total cells evaluated in sorted human beta-cells and non-sorted dispersed islet cells cultured on 3 different matrices in control medium or with Liraglutide and/or conditioned medium (n = 7).

		Sorted beta-cells	Non-sorted cells
		Pooled treatmentsa	Control	Lira	CM	CM+Lira
% BrdU+/Ins+	BCEC	0.034±0.019	0.017±0.008	0.082±0.034 *	0.042±0.014	0.027±0.014
	804 G	0.015±0.004	0.032±0.026	0.011±0.005	0.049±0.029	0.186±0.088
	HTB9	0.097±0.082	0.028±0.025	0.047±0.034	0.097±0.040	0.035±0.024
		Sorted beta-cells	Non-sorted cells
Number of cells counted	Total cells	85'412	525'001
	Beta cells	84'283	232'826
	BrdU+/Ins+	22	104
% BrdU+/Ins+	Pooled matrices and treatments	0.051±0.020	0.055±0.011

^aFor each matrix, the numbers of proliferating beta-cells were pooled from dishes treated with control media ±Liraglutide or condit.media ± Liraglutide.

^*represents p<0.05 as tested by Mann-Whitney.

CM, conditioned medium; Lira, Liraglutide; BCEC, bovine corneal endothelial cell; 804 G, rat bladder carcinoma; HTB9, human bladder carcinoma.